title: Cytogenetic analysis of human oocytes parthenogenetically activated by puromycin.
abstract: OBJECTIVE
  Treatment of aged human oocytes by puromycin allows a high rate of parthenogenetic activation and development until the first cleavage division. This technique was used for the study of the chromosome complement of oocytes which remained unfertilized after in vitro fertilization. Three hundred four unfertilized oocytes were treated with 10 micrograms/ml puromycin for 6-8 hr and further cultured for 12-15 hr.
  
  
  RESULTS
  Activation occurred in 90.5% of the oocytes. Heterozygous diploids with two pronuclei predominated (61%), which is in contrast to the mouse, where the majority of oocytes activated by puromycin are uniform haploids (89%).
  
  
  CONCLUSIONS
  Therefore we conclude that puromycin treatment induces retention of the second polar body in human oocytes, unlike in mouse oocytes treated in the same way. Chromosome analysis performed on 182 oocytes suggested a nondisjunction (ND) rate for the second meiotic division of 12.7%. This is a low figure considering the fact that puromycin itself has been reported to induce nondisjunction. For the first meiotic division a ND rate of only 5.6% was found. This rate is lower than the one found in metaphase II arrested oocytes and we believe that this difference is due to the technical differences between the study of meiotic and that of mitotic chromosomes.
authors.affiliation: Department of Obstetrics/Gynecology, University Hospital, Gent, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: De Sutter
authors.forename: D
authors.initials: D
authors.lastname: Dozortsev
authors.forename: P
authors.initials: P
authors.lastname: Vrijens
authors.forename: R
authors.initials: R
authors.lastname: Desmet
authors.forename: M
authors.initials: M
authors.lastname: Dhont
mesh_terms: D002467:Cell Nucleus / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D002843:Chromatin / Q000235:genetics; D002877:Chromosomes, Human / Q000187:drug effects / Q000235:genetics; D003582:Cytogenetics; D005260:Female; D006238:Haploidy; D006801:Humans; D008540:Meiosis / Q000187:drug effects / Q000235:genetics; D008938:Mitosis / Q000187:drug effects / Q000235:genetics; D009865:Oocytes / Q000187:drug effects* / Q000502:physiology*; D010312:Parthenogenesis / Q000187:drug effects / Q000502:physiology*; D011691:Puromycin / Q000494:pharmacology*
chemical_list: D002843:Chromatin; D011691:Puromycin